tiprankstipranks
Advertisement
Advertisement
Teva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside
PremiumRatingsTeva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside
7d ago
Teva price target raised to $45 from $42 at Truist
Premium
The Fly
Teva price target raised to $45 from $42 at Truist
7d ago
Unusually active option classes on open April 29th
Premium
The Fly
Unusually active option classes on open April 29th
7d ago
Teva expects revenue to ‘gradually increase’ over course of year
PremiumThe FlyTeva expects revenue to ‘gradually increase’ over course of year
7d ago
Morning Movers: NXP Semi, Bloom Energy charged up after results
Premium
The Fly
Morning Movers: NXP Semi, Bloom Energy charged up after results
7d ago
Teva Posts Strong Q1 2026 Results, Eyes Share Buybacks
Premium
Company Announcements
Teva Posts Strong Q1 2026 Results, Eyes Share Buybacks
8d ago
Teva put volume heavy and directionally bearish
PremiumThe FlyTeva put volume heavy and directionally bearish
8d ago
TEVA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TEVA Earnings this Week: How Will it Perform?
10d ago
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100